MXCT — MaxCyte Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for MaxCyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	255	227	168	154	103
Net Total Accounts Receivable
Net Total Receivables	6.88	13.6	5.78	4.68	3.5
Total Inventory
Prepaid Expenses
Total Current Assets	270	252	190	172	118
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.4	33.6	34.8	30.5	28.5
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	284	287	268	239	203
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	15.6	15.4	17.9	15.8	14.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.2	32.7	36.1	33.2	31
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	263	254	232	206	171
Total Liabilities & Shareholders' Equity	284	287	268	239	203
Total Common Shares Outstanding